PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2020 Earnings Conference Call November 12, 2020 8:00 AM ET
Company Participants
Deanne Randolph - Investor Relations
Frank Bedu-Addo - Chief Executive Officer
Lauren Wood - Chief Medical Officer
Michael King - Interim Chief Financial Officer
Conference Call Participants
Joe Pantginis - H.C. Wainwright
Ahu Demir - Noble Capital
Jim Malloy - Alliance Global Partners
Operator
Greetings. Welcome to PDS Biotechnology's Third Quarter 2020 Earnings Call. At this time all, participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, that this conference is being recorded.
At this time, I'll turn the floor over to Deanne Randolph with Media, Investor Relations. Deanne, you may now begin.
Deanne Randolph
Thank you. Good morning and welcome to PDS Biotechnology's third quarter 2020 earnings conference call and audio webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren Wood, Chief Medical Officer; and Michael King, Interim Chief Financial Officer.
Yesterday afternoon, PDS Biotech issued a press release announcing financial results for the three months ended September 30, 2020. We encourage everyone to read yesterday's press release as well as PDS Biotech's quarterly report on Form 10-Q, which will be filed with the SEC tomorrow.
The company's press release is available on PDS Biotech's website at pdsbiotech.com and the quarterly report will be posted tomorrow. In addition, this conference call is being webcast through the company's website and will be archived there for future reference.
Before we begin, I would like to caution listeners that comments made by management during the conference call will include forward-looking statements within the meaning of federal securities laws, including the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve material risks and uncertainties and the company's actual
- Read more current PDSB analysis and news
- View all earnings call transcripts